Please use this identifier to cite or link to this item:
https://doi.org/10.21256/zhaw-25341
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Höglinger, Marc | - |
dc.contributor.author | Wirth, Brigitte | - |
dc.contributor.author | Carlander, Maria | - |
dc.contributor.author | Caviglia, Cornelia | - |
dc.contributor.author | Frei, Christian | - |
dc.contributor.author | Rhomberg, Birgitta | - |
dc.contributor.author | Rohrbasser, Adrian | - |
dc.contributor.author | Trottmann, Maria | - |
dc.contributor.author | Eichler, Klaus | - |
dc.date.accessioned | 2022-07-27T08:12:39Z | - |
dc.date.available | 2022-07-27T08:12:39Z | - |
dc.date.issued | 2022-06-18 | - |
dc.identifier.issn | 1618-7601 | de_CH |
dc.identifier.issn | 1618-7598 | de_CH |
dc.identifier.uri | https://digitalcollection.zhaw.ch/handle/11475/25341 | - |
dc.description.abstract | Objective: To evaluate the impact of a DMP for patients with diabetes mellitus in a Swiss primary care setting. Methods: In a prospective observational study, we compared diabetes patients in a DMP (intervention group; N?=?538) with diabetes patients receiving usual care (control group; N?=?5050) using propensity score matching with entropy balancing. Using a difference-in-difference (DiD) approach, we compared changes in outcomes from baseline (2017) to 1-year (2017/18) and to 2-year follow-up (2017/19). Outcomes included four measures for guideline-adherent diabetes care, hospitalization risk, and health care costs. Results: We identified a positive impact of the DMP on the share of patients fulfilling all measures for guideline-adherent care [DiD 2017/18: 7.2 percentage-points, p?<?0.01; 2017/19: 8.4 percentage-points, p?<?0.001]. The hospitalization risk was lower in the intervention group in both years, but only statistically significant in the 1-year follow-up [DiD 2017/18: – 5.7 percentage-points, p?<?0.05; 2017/19: – 3.9 percentage points, n.s.]. The increase in health care costs was smaller in the intervention than in the control group [DiD 2017/18: CHF – 852; 2017/19: CHF – 909], but this effect was not statistically significant. Conclusion: The DMP under evaluation seems to exert a positive impact on the quality of diabetes care, reflected in the increase in the measures for guideline-adherent care and in a reduction of the hospitalization risk in the intervention group. It also might reduce health care costs, but only a longer follow-up will show whether the observed effect persists over time. | de_CH |
dc.language.iso | en | de_CH |
dc.publisher | Springer | de_CH |
dc.relation.ispartof | The European Journal of Health Economics | de_CH |
dc.rights | http://creativecommons.org/licenses/by/4.0/ | de_CH |
dc.subject | Diabetes | de_CH |
dc.subject | Disease management | de_CH |
dc.subject | Primary care | de_CH |
dc.subject | Program evaluation | de_CH |
dc.subject | Quality of care | de_CH |
dc.subject | Structured treatment program | de_CH |
dc.subject.ddc | 362.1041: Gesundheitsökonomie | de_CH |
dc.subject.ddc | 616: Innere Medizin und Krankheiten | de_CH |
dc.title | Impact of a diabetes disease management program on guideline-adherent care, hospitalization risk and health care costs : a propensity score matching study using real-world data | de_CH |
dc.type | Beitrag in wissenschaftlicher Zeitschrift | de_CH |
dcterms.type | Text | de_CH |
zhaw.departement | School of Management and Law | de_CH |
zhaw.organisationalunit | Winterthurer Institut für Gesundheitsökonomie (WIG) | de_CH |
dc.identifier.doi | 10.1007/s10198-022-01486-2 | de_CH |
dc.identifier.doi | 10.21256/zhaw-25341 | - |
dc.identifier.pmid | 35716315 | de_CH |
zhaw.funding.eu | No | de_CH |
zhaw.issue | 3 | de_CH |
zhaw.originated.zhaw | Yes | de_CH |
zhaw.pages.end | 478 | de_CH |
zhaw.pages.start | 469 | de_CH |
zhaw.publication.status | publishedVersion | de_CH |
zhaw.volume | 24 | de_CH |
zhaw.publication.review | Peer review (Publikation) | de_CH |
zhaw.author.additional | No | de_CH |
zhaw.display.portrait | Yes | de_CH |
Appears in collections: | Publikationen School of Management and Law |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
2022_Hoeglinger-etal_Impact-diabetes-disease-management.pdf | 551.4 kB | Adobe PDF | View/Open |
Show simple item record
Höglinger, M., Wirth, B., Carlander, M., Caviglia, C., Frei, C., Rhomberg, B., Rohrbasser, A., Trottmann, M., & Eichler, K. (2022). Impact of a diabetes disease management program on guideline-adherent care, hospitalization risk and health care costs : a propensity score matching study using real-world data. The European Journal of Health Economics, 24(3), 469–478. https://doi.org/10.1007/s10198-022-01486-2
Höglinger, M. et al. (2022) ‘Impact of a diabetes disease management program on guideline-adherent care, hospitalization risk and health care costs : a propensity score matching study using real-world data’, The European Journal of Health Economics, 24(3), pp. 469–478. Available at: https://doi.org/10.1007/s10198-022-01486-2.
M. Höglinger et al., “Impact of a diabetes disease management program on guideline-adherent care, hospitalization risk and health care costs : a propensity score matching study using real-world data,” The European Journal of Health Economics, vol. 24, no. 3, pp. 469–478, Jun. 2022, doi: 10.1007/s10198-022-01486-2.
HÖGLINGER, Marc, Brigitte WIRTH, Maria CARLANDER, Cornelia CAVIGLIA, Christian FREI, Birgitta RHOMBERG, Adrian ROHRBASSER, Maria TROTTMANN und Klaus EICHLER, 2022. Impact of a diabetes disease management program on guideline-adherent care, hospitalization risk and health care costs : a propensity score matching study using real-world data. The European Journal of Health Economics. 18 Juni 2022. Bd. 24, Nr. 3, S. 469–478. DOI 10.1007/s10198-022-01486-2
Höglinger, Marc, Brigitte Wirth, Maria Carlander, Cornelia Caviglia, Christian Frei, Birgitta Rhomberg, Adrian Rohrbasser, Maria Trottmann, and Klaus Eichler. 2022. “Impact of a Diabetes Disease Management Program on Guideline-Adherent Care, Hospitalization Risk and Health Care Costs : A Propensity Score Matching Study Using Real-World Data.” The European Journal of Health Economics 24 (3): 469–78. https://doi.org/10.1007/s10198-022-01486-2.
Höglinger, Marc, et al. “Impact of a Diabetes Disease Management Program on Guideline-Adherent Care, Hospitalization Risk and Health Care Costs : A Propensity Score Matching Study Using Real-World Data.” The European Journal of Health Economics, vol. 24, no. 3, June 2022, pp. 469–78, https://doi.org/10.1007/s10198-022-01486-2.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.